Red light therapy is safe for most dermatologic conditions. But overuse or misuse has been linked to reports of headaches, ocular injuries and other adverse events that can be avoided with some common...

The International Psoriasis Council has released a list of five recommendations for prioritized action items that will help dermatologists incorporate metabolic disease considerations into psoriasis c...

In this episode, guest Adewole S. Adamson, MD, MPP, discusses use of sunscreen, outlines how to decipher labels and debunks myths surrounding sunscreen.

Responsible research practices are top of our minds after recently attending the 9th World Conference on Research Integrity (WCRI) in Vancouver, Canada. It is likely of no surprise that artificial int...

Nearly half of patients with psoriasis screened for cardiovascular disease risk factors at the recommendation of their dermatologist had elevated blood pressure, cholesterol or HbA1c, suggesting a nee...

Adults with moderate to severe psoriasis and overweight or obesity were more likely to achieve complete skin clearance plus improvement in body weight with combination tirzepatide plus ixekizumab vs. ...

Stand Up For Science has become a formal organization and adopted a new strategy that's more confrontational with grassroots tactics

Podcast Episode · Why Should I Trust You? · February 26 · 1h 2m

Treatment with once-daily brepocitinib improved skin disease, muscle and physical function measures for adults with dermatomyositis while minimizing steroid burden, with benefits as early as 4 weeks a...

Hidradenitis suppurativa is a chronic autoinflammatory condition that is estimated to affect approximately 1% to 4% of people in the United States, often characterized by painful lesions that can be d...

The American Academy of Dermatology, currently led by Susan C. Taylor, MD, FAAD, is supporting its members during a time of rapid change and a challenging reimbursement environment, both complicating ...

At-home LED face masks, especially those that combine red and blue light, can complement prescription and over-the-counter acne treatments, but new data suggest consumers should be cautious before sel...

The FDA approved Anzupgo for the treatment of moderate to severe chronic hand eczema in adults who do not adequately respond to or cannot receive topical corticosteroids, Leo Pharma announced in a pre...

An extended day in the sun can be anything but relaxing for those who develop polymorphous light eruption, an uncomfortable, often itchy sun rash that can persist for several days. Polymorphous light ...

Join Healio | Dermatology’s Chief Medical Editor, Joel M. Gelfand, MD, MSCE, for a LinkedIn livestream! He will be joined by Susan C. Taylor, MD, FAAD to explore how emerging technologies and AI are t...

The National Psoriasis Foundation raised more than $1.5 million during its annual Commit to Cure gala, breaking previous fundraising records and furthering ongoing efforts to find a cure for psoriatic...

A new consensus statement endorsed by the National Psoriasis Foundation formally defined on-treatment remission for plaque psoriasis, an effort to improve the ability of clinicians and stakeholders to...

From 2020 to 2024, universities contributed patents underpinning 50% of FDA-approved drugs. 87% of those academic breakthroughs came from American institutions.

Abdominal obesity is a greater risk factor for psoriasis than total body fat, according to an analysis of imaging data, suggesting clinicians should consider treatments that also reduce cardiometaboli...